Quipt Home Medical Announces Shareholder Approval of Acquisition by Kingswood and Forager
Quipt Home Medical Shareholders Overwhelmingly Approve Acquisition by Kingswood and Forager
Key Highlights from the Special Shareholder Meeting
- Acquisition Details: Quipt Home Medical Corp. (NASDAQ: QIPT; TSX: QIPT), a leading U.S.-based provider of home medical equipment and respiratory care services, announced that shareholders have voted in favor of a plan of arrangement for the company to be acquired by affiliates of Kingswood Capital Management, L.P. and Forager Capital Management, LLC.
- Purchase Price: Under the terms of the agreement, all issued and outstanding common shares of Quipt will be acquired for cash consideration of US\$3.65 per share.
- Shareholder Support: The special resolution related to the arrangement received extremely strong support from shareholders:
- 98.9% of shares voted at the meeting were in favor of the transaction.
- 98.7% of shares voted, after excluding votes required to be omitted under Canadian minority protection rules (Multilateral Instrument 61-101), supported the deal.
- Quorum was robust, with 29,672,136 shares represented, or approximately 66.93% of all outstanding shares.
- Next Steps: The company is scheduled to seek a final order from the Supreme Court of British Columbia on March 5, 2026. If all regulatory and exchange approvals and closing conditions are met, the transaction is expected to close in the near term.
Critical Information for Shareholders
- Shareholder Value: The cash offer of US\$3.65 per share provides a defined exit price for investors, which could be immediately impactful for share valuation and trading.
- Regulatory Approvals: The completion of the deal remains subject to court approval and satisfaction of all regulatory and exchange requirements. There is a risk that the deal could be delayed or not completed if these conditions are not met.
- Potential Share Delisting: Upon successful completion of the arrangement, Quipt’s shares are expected to be delisted from the TSX and NASDAQ, and the company will cease to be a reporting issuer under Canadian and U.S. securities laws. This is a significant change for current holders, as their shares will no longer trade publicly.
- Risk Factors: The company has outlined a comprehensive set of risks and uncertainties that could impact the completion and benefits of the arrangement. These include, but are not limited to, regulatory and court approval risks, market volatility, integration risks, changes in reimbursement rates, and increased competition.
- Further Information: Investors are encouraged to review the company’s definitive proxy statement and management information circular, which are available on SEDAR+ and the company’s website. The company has also filed a Form 8-K regarding the voting results with the SEC.
About Quipt Home Medical Corp.
Quipt Home Medical specializes in in-home monitoring and disease management services, with a primary focus on end-to-end respiratory solutions for the U.S. healthcare market. The company is pursuing an organic growth strategy by increasing revenue per patient through the consolidation of services and expansion into additional chronic disease management, including heart and pulmonary diseases, sleep disorders, and reduced mobility.
Forward-Looking Statements
The company cautions investors that forward-looking statements regarding the arrangement, its anticipated benefits, timing, and completion are subject to numerous risks and uncertainties. These include regulatory approvals, market and operational risks, and other factors that could cause results to differ materially from current expectations. Investors should review all risk factors detailed in Quipt’s recent filings, including its most recent Annual Report and Quarterly Reports.
Contact Information
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult with professional advisors before making investment decisions. Quipt Home Medical’s forward-looking statements are subject to risks outlined in their official filings. The company undertakes no obligation to update forward-looking statements except as required by law.
View Quipt Home Medical Corp. Historical chart here
